TECOGEN INC/WALTHAM MA (TGEN) Fundamental Analysis & Valuation

NYSEARCA:TGEN • US87876P2011

Current stock price

2.46 USD
-0.11 (-4.28%)
Last:

This TGEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. TGEN Profitability Analysis

1.1 Basic Checks

  • TGEN had negative earnings in the past year.
  • TGEN had a positive operating cash flow in the past year.
  • In the past 5 years TGEN reported 4 times negative net income.
  • In multiple years TGEN reported negative operating cash flow during the last 5 years.
TGEN Yearly Net Income VS EBIT VS OCF VS FCFTGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

  • The Return On Assets of TGEN (-15.31%) is worse than 80.95% of its industry peers.
  • TGEN has a Return On Equity of -46.53%. This is amonst the worse of the industry: TGEN underperforms 80.95% of its industry peers.
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROIC N/A
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
TGEN Yearly ROA, ROE, ROICTGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • With an excellent Gross Margin value of 43.64%, TGEN belongs to the best of the industry, outperforming 88.10% of the companies in the same industry.
  • In the last couple of years the Gross Margin of TGEN has grown nicely.
  • TGEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
TGEN Yearly Profit, Operating, Gross MarginsTGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. TGEN Health Analysis

2.1 Basic Checks

  • TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TGEN has been increased compared to 1 year ago.
  • TGEN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for TGEN is higher compared to a year ago.
TGEN Yearly Shares OutstandingTGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
TGEN Yearly Total Debt VS Total AssetsTGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of 0.53, we must say that TGEN is in the distress zone and has some risk of bankruptcy.
  • TGEN's Altman-Z score of 0.53 is on the low side compared to the rest of the industry. TGEN is outperformed by 88.10% of its industry peers.
  • TGEN has a debt to FCF ratio of 0.63. This is a very positive value and a sign of high solvency as it would only need 0.63 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.63, TGEN belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
  • TGEN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • TGEN's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. TGEN outperforms 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Altman-Z 0.53
ROIC/WACCN/A
WACC10.33%
TGEN Yearly LT Debt VS Equity VS FCFTGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that TGEN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, TGEN is doing worse than 78.57% of the companies in the same industry.
  • A Quick Ratio of 0.74 indicates that TGEN may have some problems paying its short term obligations.
  • TGEN has a worse Quick ratio (0.74) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.74
TGEN Yearly Current Assets VS Current LiabilitesTGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TGEN Growth Analysis

3.1 Past

  • The earnings per share for TGEN have decreased strongly by -220.48% in the last year.
  • The Revenue has been growing slightly by 2.46% in the past year.
  • Measured over the past years, TGEN shows a decrease in Revenue. The Revenue has been decreasing by -5.52% on average per year.
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%-12.47%

3.2 Future

  • Based on estimates for the next years, TGEN will show a very strong growth in Earnings Per Share. The EPS will grow by 38.30% on average per year.
  • Based on estimates for the next years, TGEN will show a very strong growth in Revenue. The Revenue will grow by 22.23% on average per year.
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
EPS Next 5Y38.3%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y-1.06%
Revenue Next 5Y22.23%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TGEN Yearly Revenue VS EstimatesTGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
TGEN Yearly EPS VS EstimatesTGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. TGEN Valuation Analysis

4.1 Price/Earnings Ratio

  • TGEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TGEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TGEN Price Earnings VS Forward Price EarningsTGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TGEN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 23.75
EV/EBITDA N/A
TGEN Per share dataTGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

  • A cheap valuation may be justified as TGEN's earnings are expected to decrease with -38.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TGEN Dividend Analysis

5.1 Amount

  • No dividends for TGEN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TGEN Fundamentals: All Metrics, Ratios and Statistics

TECOGEN INC/WALTHAM MA

NYSEARCA:TGEN (3/30/2026, 8:04:00 PM)

2.46

-0.11 (-4.28%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)03-18
Earnings (Next)05-11
Inst Owners27.9%
Inst Owner Change-4.23%
Ins Owners22.95%
Ins Owner Change1.18%
Market Cap73.43M
Revenue(TTM)25.00M
Net Income(TTM)-4.76M
Analysts82.86
Price Target10.2 (314.63%)
Short Float %6.84%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)-33.33%
PT rev (3m)-33.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.25
P/FCF 23.75
P/OCF 18.08
P/B 7.18
P/tB 13.67
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.1
FCFY4.21%
OCF(TTM)0.14
OCFY5.53%
SpS0.76
BVpS0.34
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.31%
ROE -46.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.64%
FCFM 13.67%
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.63
Debt/EBITDA N/A
Cap/Depr 175.01%
Cap/Sales 4.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.74
Altman-Z 0.53
F-Score4
WACC10.33%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
EPS Next 5Y38.3%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%-12.47%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y-1.06%
Revenue Next 5Y22.23%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-61.05%
EBIT Next 3Y69.76%
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A

TECOGEN INC/WALTHAM MA / TGEN Fundamental Analysis FAQ

What is the fundamental rating for TGEN stock?

ChartMill assigns a fundamental rating of 2 / 10 to TGEN.


What is the valuation status of TECOGEN INC/WALTHAM MA (TGEN) stock?

ChartMill assigns a valuation rating of 1 / 10 to TECOGEN INC/WALTHAM MA (TGEN). This can be considered as Overvalued.


What is the profitability of TGEN stock?

TECOGEN INC/WALTHAM MA (TGEN) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for TGEN stock?

The Earnings per Share (EPS) of TECOGEN INC/WALTHAM MA (TGEN) is expected to decline by -53% in the next year.